EC: 1.14.15.16
vitamin D3 24-hydroxylase (calcitriol,adrenodoxin:oxygen oxidoreductase (24-hydroxylating))
Pathways
| pathway id | name |
|---|---|
| Reactome:R-HSA-196791 | Vitamin D (calciferol) metabolism |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-556833 | Metabolism of lipids |
| Reactome:R-MMU-8957322 | Metabolism of steroids |
| Reactome:R-MMU-211859 | Biological oxidations |
| Reactome:R-RNO-211945 | Phase I - Functionalization of compounds |
| Reactome:R-HSA-556833 | Metabolism of lipids |
| Reactome:R-RNO-211859 | Biological oxidations |
| Reactome:R-HSA-211945 | Phase I - Functionalization of compounds |
| Reactome:R-MMU-196791 | Vitamin D (calciferol) metabolism |
| Reactome:R-MMU-211945 | Phase I - Functionalization of compounds |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-556833 | Metabolism of lipids |
| Reactome:R-RNO-8957322 | Metabolism of steroids |
| Reactome:R-RNO-211897 | Cytochrome P450 - arranged by substrate type |
| Reactome:R-RNO-211916 | Vitamins |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-8957322 | Metabolism of steroids |
| Reactome:R-HSA-211897 | Cytochrome P450 - arranged by substrate type |
| Reactome:R-HSA-211916 | Vitamins |
| Reactome:R-MMU-211897 | Cytochrome P450 - arranged by substrate type |
| Reactome:R-MMU-211916 | Vitamins |
| Reactome:R-RNO-196791 | Vitamin D (calciferol) metabolism |
| PathBank:SMP0120629 | Aromatase Deficiency |
| PathBank:SMP0120641 | Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0120649 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0120451 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0120640 | 21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0063672 | Steroidogenesis |
| PathBank:SMP0120437 | 17-beta Hydroxysteroid Dehydrogenase III Deficiency |
| PathBank:SMP0120630 | 17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0120642 | Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0120650 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0063594 | Androgen and Estrogen Metabolism |
| PathBank:SMP0120450 | Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0120470 | Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0120639 | 11-beta-Hydroxylase Deficiency (CYP11B1) |